Source: Annual Congress 2003 - Advances in pathobiology of parenchymal and airway disorders



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bargagli, C. Bigliazzi, G. M. Perari, A. Leonini, C. Vagaggini, P. Rottoli (Siena, Italy). Chronic eosinophilic pneumonia: clinical study, analysis of BAL, tryptase assay. Eur Respir J 2003; 22: Suppl. 45, 1153

Member's Comments

No comment yet.

Related content which might interest you: The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 A clinical study of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Eosinophilic pneumonia (acute, chronic) Source: Respipedia Article Year: 2017 Acute interstitial pneumonia: report of a series Source: Eur Respir J 2003; 21: 187-191 Year: 2003 Chronic cough and neutrophilic BAL in children Source: Annual Congress 2005 - Paediatric bronchology - a broad field Year: 2005 Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Cellular composition of bronchoalveolar lavage (BAL) as inflammation indicator in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology Year: 2014 Apoptotic response of eosinophils in chronic eosinophilic pneumonia Source: Eur Respir J 2001; 17: 190-194 Year: 2001 Increased urinary LTE4 in severe asthma and COPD: interim report from the BIOAIR study Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007 Immunological analysis in chronic eosinophilic pneumonia; eosinophil active cytokines and surface antigens of eosinophils Source: Eur Respir J 2001; 18: Suppl. 33, 272s Year: 2001 Impact of lymphocyte differential count in BALF on the mortality of patients with acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis Source: Eur Respir J 2003; 21: 407-413 Year: 2003 Comparison of blood and sputum analysis in evaluation of eosinophilic COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Comparison of two published definitions of sputum neutrophilia show clinical measures of disease are more severe in neutrophilic asthma (NA) than non-neutrophilic asthma (NNA) using >40% sputum neutrophils as the definition of disease. Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Airway wall eosinophilia in severe asthmatic children: predictive values for noninvasive tests Source: Annual Congress 2006 - Markers of paediatric airway disease Year: 2006